NEURONETICS INC (STIM)       6.2  -0.04 (-0.64%)

6.2  -0.04 (-0.64%)

US64131A1051 - Common Stock

News Image
2 days ago - Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image
4 days ago - Neuronetics

Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category

NeuroStar’s technology once again recognized as an effective non-drug treatment for patients...

News Image
4 days ago - Neuronetics

Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category

NeuroStar’s technology once again recognized as an effective non-drug treatment for patients

News Image
18 days ago - Neuronetics

Neuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference

MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing,...

News Image
25 days ago - Neuronetics

Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy...

News Image
25 days ago - Neuronetics

Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy

News Image
a month ago - Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image
a month ago - Neuronetics

Neuronetics Reports Third Quarter 2022 Financial and Operating Results

MALVERN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision...

News Image
a month ago - Neuronetics

Neuronetics Announced as Winner by 2022 Merit Awards for Technology

NeuroStar technology is acknowledged for its innovation and accessibility as a non-drug treatment for mental health

News Image
a month ago - Neuronetics

Neuronetics Announced as Winner by 2022 Merit Awards for Technology

NeuroStar technology is acknowledged for its innovation and accessibility as a non-drug treatment for mental health...

News Image
a month ago - Neuronetics

Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health

Published and Proposed Medicare Coverage through CGS and NGS MACs Will Reduce Number of Medication Trials, Leading to Increased Eligibility for TMS

News Image
a month ago - Neuronetics

Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health

Published and Proposed Medicare Coverage through CGS and NGS MACs Will Reduce Number of Medication Trials, Leading to Increased Eligibility for TMS...

News Image
2 months ago - Neuronetics

Neuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image
2 months ago - Neuronetics

Neuronetics Launches Innovations To NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform

Upgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need...

News Image
3 months ago - Neuronetics

Neuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting Ceremony

The state-of-the-art training center is the first of its kind to further best practices with transformative NeuroStar Advanced Therapy for Mental Health...

News Image
3 months ago - Neuronetics

Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health

Latest NeuroStar innovation to simplify the motor threshold determination for clinicians...

News Image
4 months ago - Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image
4 months ago - Neuronetics

Neuronetics Reports Second Quarter 2022 Financial and Operating Results

MALVERN, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision...

News Image
4 months ago - Neuronetics

Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference

MALVERN, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing,...